Oregon Surgical Institute to Implement Zimmer Biomet Signature Solutions Outpatient Program

Zimmer Biomet Holdings Inc., a global leader in musculoskeletal healthcare, announced an agreement with Oregon Surgical Institute, a new ambulatory surgery center (ASC) in Beaverton, Ore., to implement Zimmer Biomet Signature Solutions Outpatient Program. Oregon Surgical Institute, a joint venture between Regent Surgical Health and West End Surgical LLC, is designed specifically to treat complex cases and procedures focused on total joint replacement and spine disorders.
 
As part of the Zimmer Biomet Signature Solutions Outpatient Program, Oregon Surgical Institute will implement Consulting Services, a suite of technologies that assist institutions in improving their bottom lines and quality of care, and HealthLoop, a technology platform that engages patients at home before their admission and after discharge to continuously guide, educate and assess the status of their recovery. Together, these services better connect healthcare professionals with their patients, delivering efficiencies and cost savings.
 
“We’re excited to implement Zimmer Biomet Signature Solutions Outpatient Program at Oregon Surgical Institute’s new ambulatory surgery center,” said David Nolan, Zimmer Biomet Group  President of Biologics, Extremities, Sports Medicine, Surgical, Trauma, Foot and Ankle, Office Based Technologies and Zimmer Biomet Signature Solutions. “We are witnessing a shift in the healthcare marketplace as additional ASCs are developed across the country. Zimmer Biomet is dedicated to providing offerings that support the needs of these outpatient surgery centers.”

Robust outpatient platforms are pertinent in response to an increasing need for more efficient patient care and growth in today’s changing healthcare landscape. ASCs provide value to patients as these facilities allow patients to undergo outpatient procedures quickly and efficiently without extended hospital stays, therefore reducing hospital costs, enhancing patient experiences and overall patient satisfaction with the ultimate goal of improving patient outcomes. 
 
“Zimmer Biomet’s Signature Solutions Outpatient Program offerings match what is needed for efficiencies in outpatient surgery,” said Chris Stine, director of Bundled Payments at Regent Surgical Health. “By improving efficiencies and patient outcomes, we will continue to advance our efforts in building an outpatient center of excellence that enhances quality of care and lowers cost of care while driving procedures from hospitals to ambulatory surgery centers.”
 
Since its debut in July 2016, Zimmer Biomet Signature Solutions continues to gain momentum in both inpatient and outpatient facilities as these institutions shift to value-based healthcare models and further focus on providing excellent patient outcomes, while maximizing procedural and cost efficiencies across the entire episode of care.
 
Founded in 1927 and headquartered in Warsaw, Ind., Zimmer Biomet designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office based technologies; spine, craniomaxillofacial and thoracic products; dental implants; and related surgical products. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. The company has operations in more than 25 countries around the world and sells products in more than 100 countries.
 
Regent Surgical Health is among the nation’s leading surgery center management and development companies, and the most experienced company offering physician/hospital ASC joint venture partnerships.